TABLE 3C.
Adverse outcomes in the study population by age.
| Age <20 | Age 20–35 | Age >35 | ||||||
|
|
|
|
||||||
| n | % (95% CI) | P-value1 | n | % (95% CI) | n | % (95% CI) | P-value1 | |
| Miscarriage | 6 | 8.6 (3.2–17.7) | NS | 25 | 10.3 (6.8–12.8) | 12 | 26.1 (14.3–41.1) | 0.007 |
| Stillbirth | 1 | 1.4 (0.04–7.7) | NS | 6 | 2.5 (0.9–5.3) | 2 | 4.3 (0.5–14.8) | NS |
| Neonatal death | 2 | 2.9 (0.4–9.9) | NS | 5 | 2.1 (0.7–4.7) | 2 | 4.3 (0.5–14.8) | NS |
| PTD | 4 | 5.7 (1.6–14.0) | NS | 11 | 4.5 (2.3–8.0) | 2 | 4.3 (0.5–14.8) | NS |
| SGA | 13 | 18.6 (10.3–29.7) | NS | 33 | 13.6 (9.6–18.6) | 3 | 6.5 (1.4–17.9) | NS |
| LBW | 3 | 4.3 (0.9–12.0) | NS | 17 | 7.0 (4.1–11.0) | 2 | 4.4 (0.5–14.8) | NS |
1Fisher’s exact test for comparison to women aged 20–35 years. NS, not significant; PTD, preterm delivery; SGA, small for gestational age; LBW, low birth weight.